Quantcast
Home > Quotes > HZNP
HZNP

Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) Quote & Summary Data

$25.95
*  
0.61
2.41%
Get HZNP Alerts
*Delayed - data as of May 21, 2019  -  Find a broker to begin trading HZNP now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
Today's High / Low
$ 26.01 / $ 24.95
Share Volume
1,378,581
50 Day Avg. Daily Volume
1,467,716
Previous Close
$ 25.34
52 Week High / Low
$ 29.44 / $ 14.89
Market Cap
4,797,736,712
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1

Intraday Chart

Shares Traded

Share Volume:
1,378,581
50 Day Avg. Daily Volume:
1,467,716

Trading Range

The current last sale of $25.95 is 74.28% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 26.01 $ 29.44
 Low: $ 24.95 $ 14.89

ETFs with HZNP as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
7.81% First Trust Nasdaq Pharmaceuticals ETF (FTXH) -0.47 (-2.25%)
3.57% Invesco Dynamic Pharmaceuticals ETF (PJP) +2.05 (3.52%)
0.27% GS ActiveBeta U.S. Small Cap Equity ETF (GSSC) +6.66 (18.11%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

Unless otherwise indicated or the context otherwise requires, references to the "Company", "we", "us" and "our" refer to Horizon Pharma plc and its consolidated subsidiaries. Overview Horizon Pharma plc is focused on researching, developing and commercializing innovative medicines that address unmet treatment needs for rare and rheumatic diseases. By expanding our growing pipeline of medicines in development and exploring all potential uses for currently marketed medicines, we strive to make a powerful difference for patients, their caregivers and physicians. Our Strategy We aspire to be a leading rare disease biopharma company that delivers innovative therapies to patients and generates high returns for our shareholders. 1 -------------------------------------------------------------------------------- Our approach has been different from typical biopharma companies.  ... More ...  

Nasdaq Official Price

Open Price:
$ 25.36
Open Date:
May 21, 2019
Close Price:
$ 25.95
Close Date:
May 21, 2019


Research Brokers before you trade

Want to trade FX?

Analyst Info